Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
8
Frequently Asked Questions
What is Market Cap of Pasithea Therapeutics Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pasithea Therapeutics Corp market cap is $5.29M.
What is the 52-week high for Pasithea Therapeutics Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pasithea Therapeutics Corp 52 week high is $17.40 as of July 06, 2024.
What is the 52-week low for Pasithea Therapeutics Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pasithea Therapeutics Corp 52 week low is $4.74 as of July 06, 2024.
What is Pasithea Therapeutics Corp stock price today?
Pasithea Therapeutics Corp stock price today is $5.08.
What was Pasithea Therapeutics Corp stock price yesterday?
Pasithea Therapeutics Corp stock price yesterday was $5.18.
What is the PE ratio of Pasithea Therapeutics Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pasithea Therapeutics Corp’s P/E ratio is -0.35.
What is the Price-to-Book ratio of Pasithea Therapeutics Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pasithea Therapeutics Corp P/B ratio is 0.2663.
What is Pasithea Therapeutics Corp's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Pasithea Therapeutics Corp's EBITDA is 0.27.
What is the 50-day moving average of Pasithea Therapeutics Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pasithea Therapeutics Corp 50-day moving average is $6.10.
How many employess does Pasithea Therapeutics Corp has?